retatrutide triple hormone receptor agonist retatrutide Phase 2 Trial of for Obesity Retatrutide: breakthrough… or still too
Description
In a 2024 study, researchers observed participants on GLP-1 medications had lower than usual fluid intake, which can contribute to dehydration as well
AP was always experienced by less than 1% of patients treated with GLP-1 RAs
It is effective on large and small blemishes
K., Khan, A., Du, F., Teicher
But if they stop these medications, weight regain occurs in the vast majority of patients, and the metabolic benefits are lost, she said in a news release
"Some people do well on lower doses for maintenance
